Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 19Breast Neoplasms 4Neoplasm Metastasis 3Thyroid Neoplasms 1Prostate Carcinoma Metastatic to the Bone 1Prostate Cancer Metastatic to Bone 1Prostate Adenocarcinoma 1Lung Neoplasms 1Hormone Refractory Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

luprolide acetate gel depot 3Magnetic Resonance Spectroscopy 3Specimen Handling 2Leuprolide 2Goserelin 2Biopsy 2relugolix 1radium Ra 223 dichloride 1niraparib 1gallium 68 PSMA-11 1fluciclovine F-18 1flibanserin 1enzalutamide 1atezolizumab 1apalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1X-Rays 1Triptorelin Pamoate 1Radium-223 1Radiotherapy, Image-Guided 1Radiotherapy 1Radiosurgery 1Radiation 1Prednisone 1PROSTVAC 1Methods 1Lymph Node Excision 1Glutamate Carboxypeptidase II 1Estramustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Prostate Adenocarcinoma × radium Ra 223 dichloride × Clear all
NCT03361735 2026-04-09

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
25 enrolled 10 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡